Between Dandelions Inc. (OTCPK:HOPS) entered into a non-binding letter of intent to acquire PainScript Corporation on February 8, 2021. In addition, Optimus announced today that they will form a telehealth and medication compliance division called Telehealth Adherence and Compliance Technologies (TACT). PainScript shall be a wholly owned subsidiary of TACT. The transaction is subject to, among other things, the completion of due diligence, the negotiation of a definitive agreement providing for the transaction and satisfaction of the conditions negotiated therein. The transaction is expected to close as soon as possible.